Drug Trial Radar · NCT02248753
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department
Last checked: Nov 19, 2026Latest source record: Jan 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
437
Actual
Start
Oct 2014
Primary completion
Nov 2018
Study completion Dec 2019
Sponsor
- Lead sponsor
- Maastricht University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ZonMw: The Netherlands Organisation for Health Research and Development
- First posted
- Sep 25, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A symptomatic episode of the heart rhythm disorder 'atrial fibrillation' (AF) is a frequent reason for visits to the emergency department. Currently, in the majority of cases, immediate (electrical or pharmacological) cardioversion is chosen, while atrial fibrillation terminates spontaneously in 70% of the cases within 24 hours. A wait-and-see approach with rate-control medication only, and when needed cardioversion within 48 hours of onset of symptoms, could be effective, safe and more cost-effective than current standard of care and could lead to a higher quality of life.
Conditions
- Atrial Fibrillation
Interventions
Pharmacological cardioversion - FlecainideDrug
Electrical cardioversionProcedure
MetoprololDrug
VerapamilDrug
DigoxinDrug
Pharmacological cardioversion - AmiodaroneDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- 12-lead ECGTime frame: 4 weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
VU University Medical Center
Amsterdam, Netherlands
Amphia Hospital
Breda, Netherlands
Catharina Ziekenhuis
Eindhoven, Netherlands
Medisch Spectrum Twente
Enschede, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Zuyderland Medical Center
Heerlen, Netherlands
Alrijne Hospital
Leiderdorp, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands
St. Antonius Hospital
Nieuwegein, Netherlands
Franciscus Gasthuis
Rotterdam, Netherlands
Antonius Ziekenhuis
Sneek, Netherlands
HagaZiekenhuis
The Hague, Netherlands
St. Elisabeth - TweeSteden Hospital
Tilburg, Netherlands
Diakonessenhuis
Utrecht, Netherlands
VieCuri Medical Center
Venlo, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.